Effect of statins and anticoagulants on prostate cancer aggressiveness

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 4, 2012, Pages 1149-1153

  Alizadeh, Moein ^a   Sylvestre, Marie Pierre ^b   Zilli, Thomas ^a   Van Nguyen, Thu ^a   Guay, Jean Pierre ^a   Bahary, Jean Paul ^a   Taussky, Daniel ^a  

^a NOTRE DAME HOSPITAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Anticoagulant; Aspirin; Cancer; Effect; Prostate; Role; Statin

Indexed keywords

ANTICOAGULANT; ASPIRIN; CANCER; EFFECT; PROSTATE; ROLE; STATIN;

DRUG PRODUCTS; PATIENT MONITORING; RADIOTHERAPY; REGRESSION ANALYSIS; UROLOGY;

DISEASES;

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ATORVASTATIN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PROSTATE SPECIFIC ANTIGEN; ROSUVASTATIN; SIMVASTATIN;

AGED; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER;

AGED; ANTICOAGULANTS; BRACHYTHERAPY; CONFIDENCE INTERVALS; DRUG THERAPY, COMBINATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; ODDS RATIO; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK;

EID: 84862701354     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.042     Document Type: Article

References (31)

1. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
2. Kopterides P, Falagas ME. Statins for sepsis: A critical and updated review. Clin Microbiol Infect 2009;15:325-334.
3. Chalmers JD, Singanayagam A, Murray MP, et al. Prior statin use is associated with improved outcomes in community-acquired pneumonia. Am J Med 2008;121:1002-1007. e1001.
4. Agarwal V, Phung OJ, Tongbram V, et al. Statin use and the prevention of venous thromboembolism: A meta-analysis. Int J Clin Pract 2010; 64:1375-1383.
5. Kandiah N, Feldman HH. Therapeutic potential of statins in Alzheimer's disease. J Neurol Sci 2009;283:230-234.
6. Demierre MF, Higgins PD, Gruber SB, et al. Statins and cancer prevention. Nat Rev Cancer 2005;5:930-942.
7. Breau RH, Karnes RJ, Jacobson DJ, et al. The association between statin use and the diagnosis of prostate cancer in a population based cohort. J Urol 2010;184:494-499.
8. Murtola TJ, Tammela TL, Maattanen L, et al. Prostate cancer and PSA among statin users in the Finnish prostate cancer screening trial. Int J Cancer 2010;127:1650-1659.
9. Hamilton RJ, Banez LL, Aronson WJ, et al. Statin medication use and the risk of biochemical recurrence after radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database. Cancer 2010;116:3389-3398.
10. Choe KS, Correa D, Jani AB, et al. The use of anticoagulants improves biochemical control of localized prostate cancer treated with radiotherapy. Cancer 2010;116:1820-1826.
11. Solomon KR, Freeman MR. Do the cholesterol-lowering properties of statins affect cancer risk? Trends Endocrinol Metab 2008;19:113-121.
12. Biasucci LM, Biasillo G, Stefanelli A. Inflammatory markers, cholesterol and statins: Pathophysiological role and clinical importance. Clin Chem Lab Med 2010;48:1685-1691.
13. Weis M, Heeschen C, Glassford AJ, et al. Statins have biphasic effects on angiogenesis. Circulation 2002;105:739-745.
14. Kusama T, Mukai M, Iwasaki T, et al. Inhibition of epidermal growth factor-induced RhoA translocation and invasion of human pancreatic cancer cells by 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. Cancer Res 2001;61:4885-4891.
15. Rao S, Porter DC, Chen X, et al. Lovastatin-mediated G1 arrest is through inhibition of the proteasome, independent of hydroxymethyl glutaryl-CoA reductase. Proc Natl Acad Sci USA 1999;96:7797-7802.
16. Matsuura M, Suzuki T, Suzuki M, et al. Statin-mediated reduction of osteopontin expression induces apoptosis and cell growth arrest in ovarian clear cell carcinoma. Oncol Rep 2011;25:41-47.
17. Parikh A, Childress C, Deitrick K, et al. Statin-induced autophagy by inhibition of geranylgeranyl biosynthesis in prostate cancer PC3 cells. Prostate 2010;70:971-981.
18. Falanga A, Marchetti M, Vignoli A, et al. Clotting mechanisms and cancer: Implications in thrombus formation and tumor progression. Clin Adv Hematol Oncol 2003;1:673-678.
19. Tagalakis V, Tamim H, Blostein M, et al. Use of warfarin and risk of urogenital cancer: A population-based, nested case-control study. Lancet Oncol 2007;8:395-402.
20. Thun MJ, Namboodiri MM, Heath CW Jr. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med 1991;325:1593-1596.
21. Sampson MT, Kakkar AK. Coagulation proteases and human cancer. Biochem Soc Trans 2002;30:201-207.
22. Amirkhosravi A, Amaya M, Siddiqui F, et al. Blockade of GpIIb/IIIa inhibits the release of vascular endothelial growth factor (VEGF) from tumor cell-activated platelets and experimental metastasis. Platelets 1999;10:285-292.
23. Vane JR. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 1971;231:232-235.
24. Kashfi K, Rigas B. Non-COX-2 targets and cancer: Expanding the molecular target repertoire of chemoprevention. Biochem Pharmacol 2005;70:969-986.
25. Greenland S. Tests for interaction in epidemiologic studies: A review and a study of power. Stat Med 1983;2:243-251.
26. Krane LS, Kaul SA, Stricker HJ, et al. Men presenting for radical prostatectomy on preoperative statin therapy have reduced serum prostate specific antigen. J Urol 2010;183:118-124.
27. Akduman B, Tandberg DJ, O'Donnell CI, et al. Effect of statins on serum prostate-specific antigen levels. Urology 2010;76:1048-1051.
28. Zhuang L, Kim J, Adam RM, et al. Cholesterol targeting alters lipid raft composition and cell survival in prostate cancer cells and xenografts. J Clin Invest 2005;115:959-968.
29. Lee SJ, Ha MJ, Lee J, et al. Inhibition of the 3-hydroxy-3- methylglutaryl-coenzyme A reductase pathway induces p53-independent transcriptional regulation of p21(WAF1/CIP1) in human prostate carcinoma cells. J Biol Chem 1998;273:10618-10623.
30. Gutt R, Tonlaar N, Kunnavakkam R, et al. Statin use and risk of prostate cancer recurrence in men treated with radiation therapy. J Clin Oncol 2010;28:2653-2659.
31. Kollmeier MA, Katz MS, Mak K, et al. Improved biochemical outcomes with statin use in patients with high-risk localized prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys 2011; 79:713-718.